(Q48744549)

English

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.

scientific article published in October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients. (English)

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

secondary progressive multiple sclerosis

0 references

multiple sclerosis

0 references

0 references

author name string

Galboiz Y

1

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

Shapiro S

2

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

Lahat N

3

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

Rawashdeh H

4

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

Miller A

5

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

publication date

1 October 2001

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

Annals of Neurology

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

50

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

4

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

443-451

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Cytokine-regulated proteases in autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Metalloproteinases and their tissue inhibitors in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP).

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Patterns of brain magnetic resonance abnormalities on T2-weighted spin echo images in clinical subgroups of multiple sclerosis: a large cross-sectional study.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

The AP-1 site and MMP gene regulation: what is all the fuss about?

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Multiple sclerosis: side effects of interferon beta therapy and their management

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Matrix metalloproteinases and diseases of the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Matrix metalloproteinases in inflammatory demyelination: targets for treatment

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FANA.1218

21 January 2018

Identifiers

10.1002/ANA.1218

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/11601495

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48744549&oldid=2042240523"